Total Current Assets
Bristol-Myers Squibb Total Current Assets decreased by 7.4% to $27.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.6%, from $30.78B to $27.21B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows relatively stable performance with a -0.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
Detailed definition
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Peer comparison
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assetsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.16B | $31.44B | $33.26B | $30.12B | $30.19B | $26.80B | $27.27B | $27.09B | $28.07B | $27.63B | $31.77B | $28.67B | $26.89B | $28.08B | $29.78B | $30.78B | $33.22B | $35.63B | $29.39B | $27.21B |
| QoQ Change | — | +7.8% | +5.8% | -9.4% | +0.2% | -11.2% | +1.8% | -0.7% | +3.6% | -1.6% | +15.0% | -9.8% | -6.2% | +4.4% | +6.1% | +3.4% | +7.9% | +7.2% | -17.5% | -7.4% |
| YoY Change | — | — | — | — | +3.5% | -14.8% | -18.0% | -10.1% | -7.0% | +3.1% | +16.5% | +5.8% | -4.2% | +1.6% | -6.3% | +7.4% | +23.5% | +26.9% | -1.3% | -11.6% |
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total current assets?
- Bristol-Myers Squibb (BMY) reported total current assets of $27.21B in Q1 2026.
- How has Bristol-Myers Squibb's total current assets changed year-over-year?
- Bristol-Myers Squibb's total current assets decreased by 11.6% year-over-year, from $30.78B to $27.21B.
- What is the long-term trend for Bristol-Myers Squibb's total current assets?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current assets has grown at a -0.5% compound annual growth rate (CAGR), from $30.19B to $29.39B.
- What does total current assets mean?
- The total value of all assets that can be turned into cash within one year.